KINGSPORT, Tenn. (WJHL) — A trial date has been set in a local lawsuit against prescription opioid manufacturers.
The “Baby Doe” lawsuit filed by the district attorneys general of Tennessee’s First, Second, and Third Judicial District will go to trial on May 18, 2020.
The original lawsuit was filed against Purdue Pharma, Mallinckrodt, and Endo Health Solutions for their alleged role in the region’s opioid addiction crisis. Mallinckrodt and Endo remain as active defendants after Purdue declared bankruptcy as it faces numerous opioid-related lawsuits from across the country.
The lawsuit is on behalf of “Baby Doe,” a child who was born with Neonatal Abstinence Syndrome, which occurs when babies are exposed to opioids in utero.